Suppr超能文献

一种模型肽激素——人促胰液素冻干制剂中颗粒的稳定性表征及外观

Stability characterization and appearance of particulates in a lyophilized formulation of a model peptide hormone-human secretin.

作者信息

Srinivasan Charudharshini, Siddiqui Akhtar, Korang-Yeboah Maxwell, Khan Mansoor A

机构信息

Division of Product Quality Research, Office of Testing and Research, OPQ, CDER, FDA, United States.

Division of Product Quality Research, Office of Testing and Research, OPQ, CDER, FDA, United States.

出版信息

Int J Pharm. 2015 Mar 15;481(1-2):104-13. doi: 10.1016/j.ijpharm.2015.01.044. Epub 2015 Jan 27.

Abstract

Drug shortages and recalls are often caused due to particulate growth in parenteral products and can have serious clinical implications. Root cause analysis of such recalls and shortages may arise due to insufficient understanding of process, formulations issues and environmental effects than often reported filtration and inadequate personnel training. Therefore, the goal of this study was to use a model peptide hormone, secretin that is currently under drug shortage, and investigate the effect of excipients on the lyophilized secretin formulation and evaluate the effect of storage and excursion temperatures. Lyophilized formulation was assayed for secretin by reverse phase HPLC. Solid state characteristics of lyophilized formulation were determined by X-ray powder diffraction (XRPD), thermal and spectroscopic methods. Dynamic light scattering (DLS) was used to detect particulates in the formulation after reconstitution. To assess the environmental impact, the lyophilized samples were stored at -20°C, 4°C, 25°C and 25°C/60%RH and analyzed at time 0, 1, 4, and 8 weeks. HPLC analyses exhibited a decrease in secretin concentration by 8 week (20-27% fold decrease). Visual observation and DLS showed particulates and increased reconstitution time (e.g., at 25°C/60%RH, particle size of ∼390 nm at day 0 to >2 μm as early as week 1; reconstitution time of ∼20s at day 0 to ∼67s at week 8). XRPD, thermal and spectroscopic methods demonstrated polymorphic transitions of mannitol and increased crystallinity in the lyophilized formulations with time. These studies potentially address the effect of product excursions outside the proposed label storage conditions which is -20°C for secretin formulation and this is the first time it has been investigated. These observations indicate that both environmental factor and excipient may have an impact on the stability of secretin formulation and appearance of particles in the product.

摘要

药品短缺和召回通常是由于注射用产品中出现微粒生长所致,可能会产生严重的临床影响。此类召回和短缺的根本原因分析,可能是由于对工艺、配方问题和环境影响的理解不足,而非通常所报道的过滤不足和人员培训不够。因此,本研究的目的是使用一种目前处于短缺状态的模型肽激素——促胰液素,研究辅料对冻干促胰液素制剂的影响,并评估储存温度和偏离温度的影响。通过反相高效液相色谱法(RP-HPLC)测定冻干制剂中的促胰液素含量。采用X射线粉末衍射(XRPD)、热分析和光谱法测定冻干制剂的固态特性。复溶后,使用动态光散射(DLS)检测制剂中的微粒。为评估环境影响,将冻干样品分别储存在-20°C、4°C、25°C和25°C/60%相对湿度(RH)条件下,并在0、1、4和8周时进行分析。高效液相色谱分析显示,8周时促胰液素浓度下降(下降20 - 27倍)。目视观察和动态光散射显示有微粒出现,且复溶时间增加(例如,在25°C/60%RH条件下,第0天颗粒大小约为390 nm,最早在第1周就增至大于2μm;第0天复溶时间约为20秒,第8周时约为67秒)。XRPD、热分析和光谱法表明,甘露醇发生了多晶型转变,且冻干制剂的结晶度随时间增加。这些研究可能解决了产品在超出建议标签储存条件(促胰液素制剂为-20°C)下的偏离影响问题,这是首次对此进行研究。这些观察结果表明,环境因素和辅料都可能对促胰液素制剂的稳定性以及产品中颗粒的出现产生影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验